Data / Drug companies / Lidocaine 5%
Lidocaine 5%: 23 companies and 40 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lidocaine 5% is listed in the FDA National Drug Code Directory by 23 companies, with 40 products in commercial distribution. 13 of the products (32.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; patch; spray, and the newest product started marketing on October 6, 2026.
The request: Get every company that lists lidocaine 5% in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 40
- Generic (ANDA) products
- 13 (32.5%)
- Application numbers
- 4
- Routes
- Topical
- Brand names
- Oxify, Nupharmisto NumbMD Lidocaine Cream, Rectal Care Cream Revivol, Lidonumb, Nupharmisto NumbMD 5% Lidocaine Cream, Topicaine 5, Lidocaine Anorectal Cream, Moshe Numbing Hemorrhoidal
- openFDA record search
- api.fda.gov
Companies that list lidocaine 5%
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| PureTek Corporation | 6 | patch | Generic drugs (ANDA) | June 15, 2023 |
| EveryMarket Inc | 5 | cream | Over the counter monograph drugs | June 16, 2026 |
| Derma Care Research Labs, LLC | 4 | cream; spray | Over the counter monograph drugs | January 30, 2023 |
| Esba Laboratories Inc. | 3 | gel; cream | Over the counter monograph drugs | March 20, 2019 |
| Weeks & Leo Co., Inc. | 3 | cream | Over the counter monograph drugs | October 6, 2026 |
| Yyba Corp | 2 | spray; cream | Over the counter monograph drugs | August 31, 2026 |
| A-S Medication Solutions | 1 | patch | Generic drugs (ANDA) | June 15, 2023 |
| Asclemed USA, Inc. | 1 | patch | Generic drugs (ANDA) | June 15, 2023 |
| Beyond Health P.A. | 1 | cream | Over the counter monograph drugs | March 1, 2022 |
| Ebanel Laboratories, Inc | 1 | cream | Over the counter monograph drugs | May 13, 2025 |
| Focus Health Group | 1 | cream | Over the counter monograph drugs | December 20, 2011 |
| Little Pharma, Inc. | 1 | cream | Over the counter monograph drugs | February 23, 2023 |
| Medcore LLC | 1 | patch | Generic drugs (ANDA) | September 9, 2024 |
| NuCare Pharmaceuticals,Inc. | 1 | patch | Generic drugs (ANDA) | June 15, 2023 |
| Otc Pharm LLC | 1 | solution | Over the counter monograph drugs | December 1, 2023 |
| Remedyrepack Inc. | 1 | patch | Generic drugs (ANDA) | September 29, 2025 |
| Rising Pharma Holdings, Inc. | 1 | cream | Over the counter monograph drugs | December 18, 2025 |
| Rite Aid Corporation | 1 | cream | Over the counter monograph drugs | March 2, 2022 |
| Shield Line LLC | 1 | cream | Over the counter monograph drugs | April 1, 2022 |
| St. Mary's Medical Park Pharmacy | 1 | patch | Generic drugs (ANDA) | August 30, 2023 |
| Telebrands Corp | 1 | cream | Over the counter monograph drugs | November 20, 2024 |
| Veridian Healthcare | 1 | spray | Over the counter monograph drugs | November 1, 2025 |
| Yaral Pharma Inc. | 1 | patch | Generic drugs (ANDA) | June 15, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 21 | 52.5% |
| Patch | 13 | 32.5% |
| Spray | 3 | 7.5% |
| Gel | 2 | 5% |
| Solution | 1 | 2.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 27 | 67.5% |
| Generic drugs (ANDA) | 13 | 32.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Amide Local Anesthetic | 40 |
| Antiarrhythmic | 40 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.